Article
Use of the yeast one-hybrid system to screen for mutations in the ligand-binding domain of the estrogen receptor.
Steroids - 1 Mar 1996
Bush S M, Folta S, Lannigan D A
Abstract excerpt
This report describes a novel yeast one-hybrid system which easily allows for the detection of mutations in the ligand-binding domain of the estrogen receptor. This screen is based on the observation that a fusion protein consisting of the GAL4 DNA-binding domain and the estrogen receptor can interact with a GAL4 upstream activating sequence and induce the expression of an integrated GAL1-lacZ gene only in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
